Navigation Links
Infrared Systems International's Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS

SILVERDALE, Wash., June 7, 2011 /PRNewswire/ -- Infrared Systems International (OTCBB: IFRS) is pleased to announce that its subsidiary, AquaLiv, Inc., has concluded a pilot study of its NatuRx™ HIV/AIDS treatment and will push forward with clinical trials in Kenya later this year.

AquaLiv concluded a pilot study with two HIV/AIDS patients this week which also happens to mark the 30th anniversary of the first reported AIDS victims on June 5th, 1981.

"The results of our pilot study indicate significant advances in the fight against HIV and AIDS," stated AquaLiv CEO Craig Hoffman. "AquaLiv's solution shows remarkable results and can do so at a much lower cost than traditional drugs currently on the market. For developing nations this could really be a game changer."

In August, Mr. Emmanuel Mutisya, a Kenyan with United Nations University, will accompany AquaLiv representatives to Kenya and aid in the identification of clinics capable of carrying out the clinical trials. "Earlier this year, Mr. Mutisya supplied 10 Kenyans with our NatuRx™ HIV/AIDS treatment. Since then, they stopped taking their costly antiretroviral drugs and their condition has improved. Mr. Mutisya is now a believer in AquaLiv technology," added Mr. Hoffman.

One study participant infected with Hepatitis C in addition to HIV observed significantly reduced Hepatitis C viral loads as an additional benefit of the treatment. Mr. Hoffman continued, "We are working on several NatuRx™ treatments for a variety of diseases. The technology has proven effective with all the bacterial and viral conditions we've tested. If given the opportunity, we are confident we could quickly have a positive impact on those infected with the new strain of deadly E.coli bacteria."

Based on AquaLiv's patented BioT™ Bioinformation Technology, NatuRx™ formulations utilize novel wave-based information composites in lieu of molecules for treatment. The solutions have no contraindications, are non-toxic and resemble common mineral water in analysis.

"The statistics are daunting. Nearly 30 million people have lost their lives since AIDS was first identified and 33 million are living with HIV today," added Bill Wright, CEO of Infrared Systems International. "An alarming 7100 people are newly infected with HIV each day. We are all committed to rolling this out as soon as possible."

AquaLiv scientists have been developing and refining the NatuRx™ HIV/AIDS treatment since 2006.

For NatuRx™ HIV/AIDS Pilot Study data, visit:

About Infrared Systems International:

Infrared Systems International, through its subsidiaries, offers unique solutions and applications for a variety of industries and emerging technologies.

AquaLiv, Inc. is a life sciences research and development company. Recent advancements in AquaLiv's technology uncovered a new field of biological information science. With direct applications in the industries of water purification, environmental science, agriculture, animal husbandry, personal use products, and medicine, AquaLiv is ready to expand its innovative product offering. To learn more about AquaLiv, please visit:

Infrared Applications Inc. is a security and safety focused company. The latest technological advancements have been incorporated into a powerful blend of wireless operation and infrared imaging to provide a system that features redundancy, connectivity, independent verification, and seamless operation for a broad spectrum of security applications. Our patented solutions benefit aviation, industrial infrastructure, military, homeland defense, and the private sector.

Focus Systems, Inc. is a service orientated, desktop virtualization, and VoIP information technology provider. Focus Systems' service essentially eliminates the need for their customers to buy, deploy, and maintain IT infrastructure. The move to cloud computing lowers customers' total cost of ownership by shifting critical systems to Focus -- including servers, backup, software, operating systems, updates, power, cooling, facility space, and internal staffing requirements. For more information, please visit:

Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Infrared Systems International

SOURCE Infrared Systems International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. LI-COR Adds Four New IRDye(R) Infrared Dye Antibodies to its Product Line
2. LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates
3. Technical Note: E-PAGE(TM) 48- and 96-Well Gels on the Odyssey(R) Infrared Imaging System
4. First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
5. Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology
6. Transmission lines for nanofocusing of infrared light
7. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
8. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
9. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
10. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
11. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together ... their BIG ideas to improve health and wellness in their schools. , Now, the ... title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):